NIH-Supported Study Finds Novel Pathway May Open Doors for New Blood Pressure Treatments – 4
Narrator: This is NIH Health Matters. I’m Joe Balintfy. A recent study is providing new research avenues that may lead to new treatments for high blood pressure. Dr. Darryl Zeldin at the National Institute of Environmental Health Sciences says the study shows that an enzyme called cytochrome P450 plays an important role.
Zeldin: What our studied showed was that mice that were genetically engineered to have high levels of these cytochrome P450s in their cardiovascular system did not develop high blood pressure, or hypertension when stimulated in ways that lead normal to developed high blood pressure.
Narrator: He adds that this is a great example of how a basic finding may lead to improved treatments. For more on this study, visit www.niehs.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.